Cargando…
Repeated otilonium bromide administration prevents neurotransmitter changes in colon of rats underwent to wrap restraint stress
Otilonium bromide (OB) is a spasmolytic drug successfully used for the treatment of irritable bowel syndrome (IBS). Its efficacy has been attributed to the block of L‐ and T‐type Ca(2+) channels and muscarinic and tachykinin receptors in the smooth muscle. Furthermore, in healthy rats, repeated OB a...
Autores principales: | Traini, Chiara, Evangelista, Stefano, Girod, Vincent, Faussone‐Pellegrini, Maria Simonetta, Vannucchi, Maria Giuliana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5345670/ https://www.ncbi.nlm.nih.gov/pubmed/27866394 http://dx.doi.org/10.1111/jcmm.13016 |
Ejemplares similares
-
Inner and Outer Portions of Colonic Circular Muscle: Ultrastructural and Immunohistochemical Changes in Rat Chronically Treated with Otilonium Bromide
por: Traini, Chiara, et al.
Publicado: (2014) -
Otilonium Bromide treatment prevents nitrergic functional and morphological changes caused by chronic stress in the distal colon of a rat IBS model
por: Traini, Chiara, et al.
Publicado: (2021) -
Otilonium Bromide Prevents Cholinergic Changes in the Distal Colon Induced by Chronic Water Avoidance Stress, a Rat Model of Irritable Bowel Syndrome
por: Traini, Chiara, et al.
Publicado: (2023) -
Telocytes express PDGFRα in the human gastrointestinal tract
por: Vannucchi, Maria-Giuliana, et al.
Publicado: (2013) -
Telocytes subtypes in human urinary bladder
por: Vannucchi, Maria-Giuliana, et al.
Publicado: (2014)